The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Mycosis Fungoides

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Mycosis Fungoides


High impact information on Mycosis Fungoides


Chemical compound and disease context of Mycosis Fungoides


Biological context of Mycosis Fungoides


Anatomical context of Mycosis Fungoides


Gene context of Mycosis Fungoides


Analytical, diagnostic and therapeutic context of Mycosis Fungoides


  1. Reversible neurologic toxicity in patients treated with standard-dose fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia. Cohen, R.B., Abdallah, J.M., Gray, J.R., Foss, F. Ann. Intern. Med. (1993) [Pubmed]
  2. Differential expression of CD24-related epitopes in mycosis fungoides/Sézary syndrome: a potential marker for circulating Sézary cells. Pirruccello, S.J., Lang, M.S. Blood (1990) [Pubmed]
  3. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. Nickoloff, B.J., Nestle, F.O., Zheng, X.G., Turka, L.A. Blood (1994) [Pubmed]
  4. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. Beljaards, R.C., Meijer, C.J., Van der Putte, S.C., Hollema, H., Geerts, M.L., Bezemer, P.D., Willemze, R. J. Pathol. (1994) [Pubmed]
  5. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. McGregor, J.M., Crook, T., Fraser-Andrews, E.A., Rozycka, M., Crossland, S., Brooks, L., Whittaker, S.J. J. Invest. Dermatol. (1999) [Pubmed]
  6. Mycosis fungoides treated with acyclovir. Mahrle, G., Thiele, B., Steigleder, G.K. JAMA (1985) [Pubmed]
  7. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study. Von Hoff, D.D., Dahlberg, S., Hartstock, R.J., Eyre, H.J. J. Natl. Cancer Inst. (1990) [Pubmed]
  8. Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. Whittemore, A.S., Holly, E.A., Lee, I.M., Abel, E.A., Adams, R.M., Nickoloff, B.J., Bley, L., Peters, J.M., Gibney, C. J. Natl. Cancer Inst. (1989) [Pubmed]
  9. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. Biggar, R.J., Horm, J., Fraumeni, J.F., Greene, M.H., Goedert, J.J. J. Natl. Cancer Inst. (1984) [Pubmed]
  10. Progression of mycosis fungoides during cimetidine therapy. Sterry, W., Hansen, G., Krüger, A., Christophers, E. Lancet (1985) [Pubmed]
  11. Treatment of mycosis fungoides with isotretinoin. Alexander, M. Lancet (1983) [Pubmed]
  12. An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma. Grever, M.R., Bisaccia, E., Scarborough, D.A., Metz, E.N., Neidhart, J.A. Blood (1983) [Pubmed]
  13. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Thangavelu, M., Finn, W.G., Yelavarthi, K.K., Roenigk, H.H., Samuelson, E., Peterson, L., Kuzel, T.M., Rosen, S.T. Blood (1997) [Pubmed]
  14. Mycosis fungoides: management with topical nitrogen mustard. Hoppe, R.T., Abel, E.A., Deneau, D.G., Price, N.M. J. Clin. Oncol. (1987) [Pubmed]
  15. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents. Dolan, M.E., McRae, B.L., Ferries-Rowe, E., Belanich, M., van Seventer, G.A., Guitart, J., Pezen, D., Kuzel, T.M., Yarosh, D.B. Clin. Cancer Res. (1999) [Pubmed]
  16. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Scarisbrick, J.J., Woolford, A.J., Russell-Jones, R., Whittaker, S.J. Blood (2000) [Pubmed]
  17. Microsatellite instability is associated with hypermethylation of the hMLH1 gene and reduced gene expression in mycosis fungoides. Scarisbrick, J.J., Mitchell, T.J., Calonje, E., Orchard, G., Russell-Jones, R., Whittaker, S.J. J. Invest. Dermatol. (2003) [Pubmed]
  18. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation. Roberts, A.A., Amano, M., Felten, C., Galvan, M., Sulur, G., Pinter-Brown, L., Dobbeling, U., Burg, G., Said, J., Baum, L.G. Mod. Pathol. (2003) [Pubmed]
  19. Percutaneous absorption of 1,3-bis (2-chloroethyl)-I-nitrosourea (BCNU, carmustine) in mycosis fungoides. Zackheim, H.S., Feldmann, R.J., Lindsay, C., Maibach, H.I. Br. J. Dermatol. (1977) [Pubmed]
  20. p19 Antigen in skin and lymph nodes of patient with advanced mycosis fungoides. Turbitt, M.L., MacKie, R.M. Lancet (1985) [Pubmed]
  21. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes. Wechsler, J., Bagot, M., Nikolova, M., Parolini, S., Martin-Garcia, N., Boumsell, L., Moretta, A., Bensussan, A. J. Pathol. (2003) [Pubmed]
  22. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). Tensen, C.P., Flier, J., Van Der Raaij-Helmer, E.M., Sampat-Sardjoepersad, S., Van Der Schors, R.C., Leurs, R., Scheper, R.J., Boorsma, D.M., Willemze, R. J. Invest. Dermatol. (1999) [Pubmed]
  23. Light microscopic, S-100 immunostaining, and ultrastructural analysis of dermatopathic lymphadenopathy, with and without associated mycosis fungoides. Herrera, G.A. Am. J. Clin. Pathol. (1987) [Pubmed]
  24. Follicular mucinosis: clinical and histopathologic study. Gibson, L.E., Muller, S.A., Leiferman, K.M., Peters, M.S. J. Am. Acad. Dermatol. (1989) [Pubmed]
  25. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Jones, D., O'Hara, C., Kraus, M.D., Perez-Atayde, A.R., Shahsafaei, A., Wu, L., Dorfman, D.M. Blood (2000) [Pubmed]
  26. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. Asadullah, K., Döcke, W.D., Haeussler, A., Sterry, W., Volk, H.D. J. Invest. Dermatol. (1996) [Pubmed]
  27. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. Kallinich, T., Muche, J.M., Qin, S., Sterry, W., Audring, H., Kroczek, R.A. J. Invest. Dermatol. (2003) [Pubmed]
  28. CCR10 is expressed in cutaneous T-cell lymphoma. Notohamiprodjo, M., Segerer, S., Huss, R., Hildebrandt, B., Soler, D., Djafarzadeh, R., Buck, W., Nelson, P.J., von Luettichau, I. Int. J. Cancer (2005) [Pubmed]
  29. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. Kakinuma, T., Sugaya, M., Nakamura, K., Kaneko, F., Wakugawa, M., Matsushima, K., Tamaki, K. J. Am. Acad. Dermatol. (2003) [Pubmed]
  30. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. Tensen, C.P., Vermeer, M.H., van der Stoop, P.M., van Beek, P., Scheper, R.J., Boorsma, D.M., Willemze, R. J. Invest. Dermatol. (1998) [Pubmed]
  31. Monoclonality of intraepidermal T lymphocytes in early mycosis fungoides detected by molecular analysis after laser-beam-based microdissection. Cerroni, L., Arzberger, E., Ardigò, M., Pütz, B., Kerl, H. J. Invest. Dermatol. (2000) [Pubmed]
  32. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Sommer, V.H., Clemmensen, O.J., Nielsen, O., Wasik, M., Lovato, P., Brender, C., Eriksen, K.W., Woetmann, A., Kaestel, C.G., Nissen, M.H., Ropke, C., Skov, S., Ødum, N. Leukemia (2004) [Pubmed]
  33. Viral infection, atopy and mycosis fungoides: a European multicentre case-control study. Morales, M.M., Olsen, J., Johansen, P., Kaerlev, L., Guénel, P., Arveux, P., Wingren, G., Hardell, L., Ahrens, W., Stang, A., Llopis, A., Merletti, F., Villanueva, M.A. Eur. J. Cancer (2003) [Pubmed]
WikiGenes - Universities